Hyperthermia Cancer Treatment Market Size and Trends

The Global Hyperthermia Cancer Treatment Market size is estimated to be valued at US$ 187.1 Mn in 2023 and is expected to reach US$ 283.1 Mn by 2030, grow at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. Hyperthermia cancer treatment involves raising the temperature of a tumor to damage and kill cancer cells. It is used along with other cancer treatments like chemotherapy and radiation therapy. The major advantage of hyperthermia treatment is that it increases blood flow and oxygen to the tumor area, making chemotherapy and radiation more effective.

Hyperthermia Cancer Treatment Market Trends:

Integration with advanced imaging techniques: The integration of hyperthermia systems with advanced 3D imaging techniques like CT, MRI, and PET scans is rising. Imaging allows accurate tumor localization, treatment planning, and real-time temperature monitoring to ensure safe thermal dose delivery. Imaging coupled with hyperthermia improves targeting and reduces side effects, driving its adoption. Vendors are increasingly integrating imaging capabilities in their systems.
Development of deep hyperthermia devices: New hyperthermia devices are being developed to safely induce therapeutic heating in deep-seated tumors. Techniques like 3D-focused ultrasound, phased-array microwave systems, and advanced RF applicators are being adopted for deep heating. For instance, the Sonotherm 1000 focused ultrasound device by Labthermics Technologies, Inc., a medical therapy products company dedicated to improving cancer treatment, enables conformal heating of deep tumors. The trend toward non-invasive deep hyperthermia is expected to continue.
Emergence of MRI-guided hyperthermia systems: MRI-guided hyperthermia therapy is an emerging trend enabling accurate thermometry and temperature control during treatments. MRI provides real-time thermal maps of the tumor and surrounding normal tissue. Companies like Pyrexar Medical offer the BSD-2000 MRI-guided hyperthermia system, which provides optimized electromagnetic energy delivery. The rising availability of MRI-compatible systems will support market growth.
Growing number of clinical trials: Many clinical studies are underway to evaluate the safety, efficacy, and optimal protocols of hyperthermia therapy for different cancer types and stages. Trials are also focused on studying combination therapies, establishing thermal dose thresholds, and quantifying therapeutic synergy. The increasing clinical evidence from trials regarding improved patient outcomes is expected to increase acceptance among clinicians and patients.